CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy

Cancer Research
Jemima EscamillaLily Wu

Abstract

Growing evidence suggests that tumor-associated macrophages (TAM) promote cancer progression and therapeutic resistance by enhancing angiogenesis, matrix-remodeling, and immunosuppression. In this study, prostate cancer under androgen blockade therapy (ABT) was investigated, demonstrating that TAMs contribute to prostate cancer disease recurrence through paracrine signaling processes. ABT induced the tumor cells to express macrophage colony-stimulating factor 1 (M-CSF1 or CSF1) and other cytokines that recruit and modulate macrophages, causing a significant increase in TAM infiltration. Inhibitors of CSF1 signaling through its receptor, CSF1R, were tested in combination with ABT, demonstrating that blockade of TAM influx in this setting disrupts tumor promotion and sustains a more durable therapeutic response compared with ABT alone.

References

Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Mar 20, 2002·Nature Reviews. Cancer·B J Feldman, D Feldman
Oct 17, 2002·Proceedings of the National Academy of Sciences of the United States of America·Hisamitsu IdeOwen N Witte
Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
Jan 4, 2003·Nature Reviews. Immunology·Siamon Gordon
Oct 3, 2003·Cancer Cell·Katharine Ellwood-YenCharles L Sawyers
Dec 20, 2005·Cancer Immunology, Immunotherapy : CII·Ashley M Miller, Pavel Pisa
Mar 8, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Antonio SicaPaola Allavena
Jun 23, 2007·International Journal of Cancer. Journal International Du Cancer·Ebba BrakenhielmLily Wu
Aug 22, 2007·Neoplasia : an International Journal for Oncology Research·Robert D LobergKenneth J Pienta
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James E Talmadge
Jun 14, 2008·Nature Reviews. Immunology·John A Hamilton
Apr 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Farbod ShojaeiNapoleone Ferrara
Nov 13, 2009·The Journal of Clinical Investigation·Jiann-Jyh LaiChawnshang Chang
Mar 12, 2010·Nature·Massimo AmmiranteMichael Karin
Sep 9, 2010·Proceedings of the National Academy of Sciences of the United States of America·Philip A WatsonCharles L Sawyers
Nov 18, 2010·Expert Opinion on Biological Therapy·Chen LüJoseph Chin
Feb 26, 2011·Hormones & Cancer·Hsing-Jien Kung
Mar 5, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gerhardt AttardJohann S de Bono
Mar 6, 2012·Endocrine-related Cancer·Hongbing ChenJiaoti Huang
Jul 21, 2012·PloS One·Minu K SrivastavaSherven Sharma
Jul 24, 2012·Blood·Jo A Van Ginderachter
Jan 17, 2013·Therapeutic Advances in Medical Oncology·Joelle El-Amm, Jeanny B Aragon-Ching
Mar 23, 2013·Cancer Cell·Michele De Palma, Claire E Lewis
Jul 19, 2014·Immunity·Roy Noy, Jeffrey W Pollard
Jul 30, 2015·The New England Journal of Medicine·William D TapGideon Bollag

❮ Previous
Next ❯

Citations

Feb 2, 2016·Cancer Letters·Stephen L ShiaoLeland W K Chung
Dec 19, 2015·Cancer Cell·Lorenzo GalluzziGuido Kroemer
Sep 7, 2016·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Minshu LiFu-Dong Shi
Jul 18, 2017·International Journal of Molecular Sciences·Geoffrey BryantDavid J Mulholland
Jan 31, 2018·Journal of Immunology Research·Geou-Yarh Liou
Jul 4, 2018·Acta Pharmacologica Sinica·Ying-Qiang LiuJian Ding
Apr 6, 2018·Endocrine-related Cancer·B CioniA M Bergman
Aug 24, 2018·Current Opinion in Urology·Rafael R Tourinho-BarbosaRafael Sanchez-Salas
Dec 1, 2018·The Prostate·Ann ErlandssonSabina Davidsson
Jul 3, 2015·The Journal of Pharmacology and Experimental Therapeutics·Wakana OhashiYuichi Hattori
Sep 7, 2017·Current Oncology Reports·Florent PeyraudAntoine Italiano
Oct 21, 2016·MedChemComm·Bibiana I FerreiraJames B Lorens
Sep 11, 2019·PLoS Computational Biology·Zhiwei JiXiaobo Zhou
Apr 8, 2017·BioMed Research International·Zhiwei JiXiaoliang Zhu
May 18, 2018·JCI Insight·Michal BeffingerMaries van den Broek
Sep 6, 2018·Genes & Development·Guocan WangRonald A DePinho
Aug 24, 2019·Prostate Cancer and Prostatic Diseases·Pei LiangWilliam J Aronson
Jun 18, 2020·Nature Reviews. Cancer·Johann S de BonoAndrea Alimonti
Aug 23, 2020·Journal of Clinical Medicine·Koji HatanoNorio Nonomura
Aug 24, 2017·The FEBS Journal·Stefano BonelliJo A Van Ginderachter
May 11, 2017·Frontiers in Oncology·Božo KrušlinMonika Ulamec
Jun 6, 2018·Frontiers in Endocrinology·Chen Hao Lo, Conor C Lynch
Aug 12, 2018·Frontiers of Medicine·Minhong Shen, Yibin Kang
Apr 16, 2019·Frontiers in Immunology·Natasha VitkinMadhuri Koti
Jan 25, 2017·Nature Reviews. Clinical Oncology·Alberto MantovaniPaola Allavena
Nov 25, 2017·The FEBS Journal·Pascale JeanninYves Delneste
Oct 21, 2019·Journal of Biomedical Science·Yibing ChenZhengzhi Zou
Mar 28, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·J Martin BrownSamuel Strober

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.